Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10161-1 | Luminespib | NVP-AUY922 | LSM-1162 |  | 53401173 |
| 10233-1 | Alpelisib | BYL719 | LSM-4256 |  | 56649450 |
| 10394-1 | Ceritinib | LDK378 |  | 57379345 | |
| 10278-2 | Topotecan | Hycamtin | LSM-5662 |  | 60700 |
| 10006-1 | AZD7762 | LSM-1006 |  | 67077825 | |
| 10171-1 | TGX221 | LSM-1172 |  | 9907093 | |
| 10444-1 | Cediranib | Recentin; AZD2171 |  | 9933475 | |
| 10478-1 | A-1210477 |  | |||
| 10245-4 | Cisplatin | CDDP; cis-Diaminodichloroplatinum; Cisplatinum; Lederplatin; Briplatin; Cismaplat | LSM-4268 |  |